Destiny Pharma

Pneumagen

This clinical-stage biotech company develops intranasal antiviral drugs to prevent and treat respiratory tract infections for patients with chronic lung diseases.

C10 PHARMA

This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.

Adjutecpharma

This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.

Blueberry Therapeutics

This clinical-stage biotechnology company develops nanomedicine therapies for patients with common dermatological and fungal infections using a proprietary delivery platform.

Discuva

This biotechnology company develops novel antibiotics to treat multi-drug resistant bacterial infections for pharmaceutical partners and healthcare providers.

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.

MetalloBio

This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.

Arsanis

This biotechnology company develops monoclonal antibodies to treat and prevent serious infectious diseases for patients with life-threatening bacterial and viral infections.